The Emerging Role of LncRNA AWPPH in Multiple Cancers: A Review Study

Mohsen Sheykhhasan1, Fateme Dermani2, Nematollah Gheibi3

  • 1Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.

PubMed

Insights

Long non-coding RNA WAPPH (lncRNA WAPPH) acts as an oncogene in various human cancers. This review highlights lncRNA WAPPH

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Long non-coding RNAs (lncRNAs) are key regulators of gene expression across epigenetic, transcriptional, post-transcriptional, and translational levels.
  • LncRNAs play a critical role in human malignancies and patient prognosis.
  • lncRNA WAPPH, located on chromosome 2q13, is a newly identified lncRNA with significant implications in cancer.

Purpose of the Study:

  • To comprehensively review and functionally discuss the role of lncRNA WAPPH in various human cancers.
  • To elucidate the oncogenic functions of lncRNA WAPPH in tumorigenesis and cancer progression.
  • To explore the involvement of lncRNA WAPPH in the biological processes of both solid and blood cancers.

Main Methods:

  • Literature review and analysis of existing research studies on lncRNA WAPPH.
  • Functional assessment of lncRNA WAPPH's role in cancer development.
  • Examination of lncRNA WAPPH's involvement in diverse cancer types, including breast, gastric, colorectal, ovarian, bladder cancers, and leukemia.

Main Results:

  • lncRNA WAPPH is frequently deregulated in a wide spectrum of human malignancies.
  • lncRNA WAPPH functions as an oncogene, promoting tumorigenesis and cancer development.
  • lncRNA WAPPH is implicated in various biological processes critical to cancer progression in both solid tumors and hematological malignancies.

Conclusions:

  • lncRNA WAPPH is a significant oncogene in human cancers.
  • lncRNA WAPPH exhibits deregulated expression across numerous cancer types.
  • lncRNA WAPPH holds potential as a diagnostic biomarker and therapeutic target for human malignancies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K